Mitochondrial pathophysiology, reactive oxygen species, and cardiovascular diseases
- PMID: 18249246
- PMCID: PMC2700041
- DOI: 10.1016/j.cvsm.2007.10.004
Mitochondrial pathophysiology, reactive oxygen species, and cardiovascular diseases
Abstract
This article discusses mitochondrial pathophysiology, reactive oxygen species, and cardiovascular diseases. Mitochondrial respiratory chains are responsible for energy metabolism/ATP production through the tricyclic antidepressant cycle, coupling of oxidative phosphorylation, and electron transfer. The mitochondrion produces reactive oxygen species as "side products" of respiration. The mitochondrial derived reactive oxygen species is involved in the pathogenesis of various clinical disorders including heart failure, hypoxia, ischemia/reperfusion injury, diabetes, neurodegenerative diseases, and the physiologic process of aging. Observational and mechanistical studies of these pathologic roles of mitochondria are discussed in depth in this article.
Figures
References
-
- Lehninger AL. Phosphorylation coupled to oxidation of dihydrodiphosphopyridine nucleotide. J Biol Chem. 1951051951;190(1):345–359. - PubMed
-
- Kroemer G, Dallaporta B, Resche-Rigon M. The mitochondrial death/life regulator in apoptosis and necrosis. Annu Rev Physiol. 19981998;60:619–642. - PubMed
-
- Campbell NA, Reece JB. Biology. 6. San Francisco: Benjamin Cummings; 2002.
-
- Lyamzaev KG, Izyumov DS, Avetisyan AV, Yang F, Pletjushkina OY, Chernyak BV. Inhibition of mitochondrial bioenergetics: the effects on structure of mitochondria in the cell and on apoptosis. Acta Biochim Pol. 20042004;51(2):553–562. - PubMed
-
- Lardy H, Reed P, Lin CH. Antibiotic inhibitors of mitochondrial ATP synthesis. Fed Proc. 1975071975;34(8):1707–1710. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
